35031 |
Pathology |
PD-L1 expression in gastric cancer determined by digital image analyse... |
VIRCHOWS ARCH 2020 10.1007/s00428-019-02653-2 |
강원기 |
2020 |
35030 |
Oncology |
Outcomes of Radiotherapy for Mesenchymal and Non-Mesenchymal Subtypes ... |
CANCERS 2020 10.3390/cancers12040943 |
강원기 |
2020 |
35029 |
Ophthalmology |
Markedly increased ocular side effect causing severe vision deteriorat... |
BMC OPHTHALMOL 2020 10.1186/s12886-019-1285-9 |
강원기 |
2020 |
35028 |
Oncology |
Impact of Prior Ramucirumab Use on Treatment Outcomes of Checkpoint In... |
TARGET ONCOL 2020 10.1007/s11523-020-00713-1 |
강원기 |
2020 |
35027 |
Oncology |
First-in-human phase I trial of anti-hepatocyte growth factor antibody... |
THER ADV MED ONCOL 2020 10.1177/1758835920926796 |
강원기 |
2020 |
35026 |
Oncology; Gastroenterology & Hepatology |
Exploratory subgroup analysis of patients with prior trastuzumab use i... |
GASTRIC CANCER 2020 10.1007/s10120-019-00970-8 |
강원기 |
2020 |
35025 |
Oncology |
Detection of Fusion Genes Using a Targeted RNA Sequencing Panel in Gas... |
J ONCOL 2020 10.1155/2020/4659062 |
강원기 |
2020 |
35024 |
Genetics & Heredity |
Comprehensive pharmacogenomic characterization of gastric cancer |
Genome Med 2020 10.1186/s13073-020-0717-8 |
강원기 |
2020 |
35023 |
Oncology |
Clinical scoring system for the prediction of survival of patients wit... |
ESMO OPEN 2020 10.1136/esmoopen-2020-000670 |
강원기 |
2020 |
35022 |
Oncology |
Claudin 18.2 expression in various tumor types and its role as a poten... |
Transl Cancer Res 2020 10.21037/tcr-19-1876 |
강원기 |
2020 |